O

Oncolys Biopharma Inc
TSE:4588

Watchlist Manager
Oncolys Biopharma Inc
TSE:4588
Watchlist
Price: 662 JPY -3.5%
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

-1.3B
+8%
Operating Cash Flow
Growth Rates:
1 Year
+22%
3 Years
+9%
5 Years
-13%
7 Years
-48%
10 Years
-
-5.4m
-266%
Investing Cash Flow
Growth Rates:
1 Year
-
3 Years
+86%
5 Years
-
7 Years
-
10 Years
-
1.1B
Financing Cash Flow
Growth Rates:
1 Year
-
3 Years
+372%
5 Years
0%
7 Years
+17 688%
10 Years
-

Cash Flow Statement
Oncolys Biopharma Inc

Rotate your device to view
Cash Flow Statement
Currency: JPY
Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023
Operating Cash Flow
Net Income
(857)
(855)
(866)
(928)
(1 028)
(1 087)
(1 210)
(1 230)
(862)
(909)
(1 300)
(2 091)
(2 077)
(1 612)
(1 532)
(1 146)
(1 444)
(1 936)
Depreciation & Amortization
15
17
17
15
7
1
2
2
2
3
4
5
6
6
4
1
1
2
Other Non-Cash Items
(7)
2
9
65
65
8
2
(12)
9
481
554
765
829
351
169
13
8
22
Cash Taxes Paid
3
3
2
2
3
3
4
4
4
4
4
4
4
4
1
1
4
(25)
Cash Interest Paid
5
4
4
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
Change in Working Capital
(59)
80
118
(56)
(81)
(19)
13
53
83
186
(46)
(144)
(70)
(488)
(511)
(585)
(11)
574
Cash from Operating Activities
(908)
N/A
(756)
+17%
(722)
+4%
(903)
-25%
(1 037)
-15%
(1 097)
-6%
(1 194)
-9%
(1 188)
+1%
(768)
+35%
(238)
+69%
(788)
-231%
(1 465)
-86%
(1 313)
+10%
(1 742)
-33%
(1 870)
-7%
(1 717)
+8%
(1 446)
+16%
(1 337)
+8%
Investing Cash Flow
Capital Expenditures
(26)
(4)
(9)
(21)
(13)
(1)
(2)
(2)
(3)
(4)
(3)
(3)
(2)
(1)
(1)
(1)
(2)
(6)
Other Items
2 017
1 759
(357)
278
734
133
33
344
100
(0)
(35)
(35)
1
0
22
21
0
0
Cash from Investing Activities
1 992
N/A
1 755
-12%
(367)
N/A
257
N/A
721
+181%
132
-82%
31
-76%
342
+1 000%
96
-72%
(4)
N/A
(38)
-748%
(38)
+0%
(2)
+95%
(1)
+45%
20
N/A
20
-1%
(1)
N/A
(5)
-266%
Financing Cash Flow
Net Issuance of Common Stock
0
0
31
37
962
1 409
0
1 188
2 132
1 007
74
245
3 320
3 085
0
(0)
0
1 223
Net Issuance of Debt
(43)
(123)
(44)
(44)
64
64
(51)
(53)
147
116
(12)
(3)
(11)
(25)
(27)
(114)
(98)
(99)
Other
0
3
3
13
17
3
0
12
12
(0)
1
(0)
31
31
(1)
(0)
0
18
Cash from Financing Activities
(38)
N/A
(120)
-214%
(10)
+92%
6
N/A
1 042
+16 126%
1 477
+42%
402
-73%
1 147
+185%
2 291
+100%
1 123
-51%
63
-94%
242
+284%
3 340
+1 279%
3 091
-7%
(28)
N/A
(114)
-310%
(98)
+14%
1 143
N/A
Change in Cash
Effect of Foreign Exchange Rates
5
(1)
(14)
(1)
4
(8)
(9)
(6)
(2)
(1)
(0)
(14)
15
38
89
67
22
21
Net Change in Cash
1 051
N/A
878
-16%
(1 112)
N/A
(641)
+42%
730
N/A
503
-31%
(770)
N/A
296
N/A
1 618
+447%
879
-46%
(763)
N/A
(1 275)
-67%
2 040
N/A
1 387
-32%
(1 788)
N/A
(1 743)
+3%
(1 523)
+13%
(178)
+88%
Free Cash Flow
Free Cash Flow
(933)
N/A
(760)
+19%
(731)
+4%
(924)
-26%
(1 050)
-14%
(1 098)
-5%
(1 196)
-9%
(1 189)
+1%
(771)
+35%
(243)
+69%
(791)
-226%
(1 468)
-86%
(1 315)
+10%
(1 743)
-33%
(1 871)
-7%
(1 718)
+8%
(1 448)
+16%
(1 343)
+7%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.